Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CBD BioAbsorb
- Development stage
- Unknown
- Lead developer
- Brains Bioceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CBD BioAbsorb is a proprietary formulation of cannabidiol (CBD) developed by BrainsBioceutical for the treatment of insomnia. The product utilizes the BioAbsorb® technology, which is designed to enhance the bioavailability and absorption of the cannabinoid. In Australia, CBD BioAbsorb has been granted Schedule 3 status, allowing it to be sold over-the-counter (OTC) by pharmacists. This regulatory classification positions the drug as a non-opioid, non-benzodiazepine alternative for sleep management. While the specific molecular targets for this formulation are not detailed in the provided source, cannabidiol is known to interact with various components of the endocannabinoid system and other signaling pathways involved in sleep-wake regulation, including cannabinoid receptors and serotonin receptors.
- Brand names
- BioAbsorb
- Other names
- cannabidiol BioAbsorbCBD (BioAbsorb)
02
Targets
CNR1 (Cannabinoid receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on CBD BioAbsorb.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CBD BioAbsorb.